PL03.09 IMpower010:Overall Survival Interim Analysis of a Phase III Study of Atezolizumab vs Best Supportive Care in Resected NSCLC

H. Wakelee, N. Altorki, E. Felip, E. Vallieres, I.O. Vynnychenko, A. Akopov, A. Martinez-Marti, A. Chella, Igor Bondarenko, S. Sugawara, Yisheng Fan, H. Kenmotsu, Y.-M. Chen, Y. Deng, F. Wu, V. McNally, E. Bennett, B.J. Gitlitz, C. Zhou